The safety and efficacy of TACE combined with apatinib on patients with advanced hepatocellular carcinoma: a retrospective study

阿帕蒂尼 医学 肝细胞癌 内科学 联合疗法 胃肠病学 不利影响 肿瘤科 酪氨酸激酶抑制剂 实体瘤疗效评价标准 肝癌 无进展生存期 癌症 化疗 临床研究阶段
作者
Zeran Yang,Guang Chen,Ye Cui,Xiao Guo-wen,Ting Su,Jianan Yu,Zhiyuan Zhang,Yanjing Han,Kai-Lan Yang,Long Jin
出处
期刊:Cancer Biology & Therapy [Informa]
卷期号:20 (3): 321-327 被引量:34
标识
DOI:10.1080/15384047.2018.1529099
摘要

As a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor (VEGFR2-TKI), apatinib has a certain anti-tumor effect for a variety of solid tumors. The present study evaluates its efficacy and safety in advanced hepatocellular carcinoma (HCC). In this study, 47 patients with advanced HCC were included. TACE monotherapy group included 22 patients that responded to TACE, while the group that received TACE and apatinib included 25 patients that progressed on TACE and were able to receive apatinib off label. Median overall survival (OS) was significantly improved in the apatinib plus TACE group compared with the TACE group. Similarly, apatinib in combination with TACE significantly prolonged median progression-free survival (PFS) compared with TACE monotherapy. Furthermore, there was a significant difference between combination therapy and monotherapy in both Barcelona clinic liver cancer (BCLC) B and BCLC C group. The combination therapy had a dramatic effect on OS and PFS for patients at both BCLC B and BCLC C level. The most common clinically adverse events of apatinib plus TACE group were fatigue, weight loss, hypertension, hand-foot syndrome and anorexia, which were manageable and tolerable. The efficacy analysis showed that there was no significant association of survival benefit with age, gender, Eastern Cooperative Oncology Group (ECOG) performance status, hypertension and hand-foot syndrome. Patients with macrovascular invasion and extrahepatic invasion showed worse survival benefits. In conclusion, apatinib combined with TACE revealed certain survival benefits for HCC patients who experienced progression following TACE, which can provide a promising strategy for HCC treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
踏实以寒完成签到,获得积分10
1秒前
Snow发布了新的文献求助10
2秒前
穆辰应助GB2312采纳,获得10
2秒前
KK完成签到,获得积分10
2秒前
0029完成签到,获得积分10
3秒前
4秒前
Moonboss完成签到 ,获得积分10
5秒前
yzy关闭了yzy文献求助
5秒前
6秒前
ldjekfj发布了新的文献求助10
8秒前
Ding发布了新的文献求助30
8秒前
bkagyin应助与光同尘采纳,获得10
8秒前
galaxy发布了新的文献求助10
9秒前
9秒前
9秒前
加油的老赵完成签到,获得积分10
10秒前
Lemon_Code应助清澈采纳,获得10
11秒前
榴莲完成签到,获得积分10
11秒前
leslie发布了新的文献求助10
12秒前
义气篮球发布了新的文献求助10
12秒前
动听的薯条完成签到,获得积分10
13秒前
123发布了新的文献求助10
13秒前
13秒前
w_w发布了新的文献求助10
13秒前
14秒前
14秒前
yp完成签到,获得积分10
15秒前
16秒前
16秒前
嘎嘎嘎发布了新的文献求助10
17秒前
18秒前
勤恳的糖豆完成签到,获得积分10
19秒前
curtisness应助卡戎529采纳,获得50
19秒前
20秒前
深情安青应助开心妙之采纳,获得10
22秒前
22秒前
慕青应助小马哥采纳,获得20
23秒前
顾建瑜发布了新的文献求助10
24秒前
25秒前
25秒前
高分求助中
Spray / Wall-interaction Modelling by Dimensionless Data Analysis 2000
Aspects of Babylonian celestial divination: the lunar eclipse tablets of Enūma Anu Enlil 500
Mathematics and Finite Element Discretizations of Incompressible Navier—Stokes Flows 500
Dictionary of socialism 350
Mixed-anion Compounds 300
Geochemistry, 2nd Edition 地球化学经典教科书第二版 300
Idoxuridine 260
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3195397
求助须知:如何正确求助?哪些是违规求助? 2844229
关于积分的说明 8049314
捐赠科研通 2508912
什么是DOI,文献DOI怎么找? 1341226
科研通“疑难数据库(出版商)”最低求助积分说明 639116
邀请新用户注册赠送积分活动 608214